TSC2 and tuberous sclerosis: As our MHPA strategy did not assess all exons of TSC2, and LOH events are not detected by our methods, this figure may be considered a minimal estimate, and the true number of micro-FAFs may approach 500,000 to 1,000,000 per TSC patient.